LUCENTIS

Welcome to the Brand page for “LUCENTIS”, which is offered here for In the statement, column 1, lines 6 thru 10, and column 2, lines 1 and 2, should be deleted and pharmaceutical preparations for the treatment of angiogenesis diseases and disorders and ocular diseases and disorders should be inserted.;pharmaceutical preparations for the treatment of [ cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, ] angiogenesis diseases and disorders, * and * ocular diseases and disorders [ , or inflammatory diseases and disorders ];.

Its status is currently believed to be active. Its class is unavailable. “LUCENTIS” is believed to be currently owned by “GENENTECH, INC.”